NO20012939L - Substituerte, heterosykliske asyl-tripeptider for bruk som trombinreseptormodulatorer - Google Patents

Substituerte, heterosykliske asyl-tripeptider for bruk som trombinreseptormodulatorer

Info

Publication number
NO20012939L
NO20012939L NO20012939A NO20012939A NO20012939L NO 20012939 L NO20012939 L NO 20012939L NO 20012939 A NO20012939 A NO 20012939A NO 20012939 A NO20012939 A NO 20012939A NO 20012939 L NO20012939 L NO 20012939L
Authority
NO
Norway
Prior art keywords
asyl
tripeptides
substituted heterocyclic
receptor modulators
thrombin receptor
Prior art date
Application number
NO20012939A
Other languages
English (en)
Other versions
NO20012939D0 (no
Inventor
David Mccomsey
Bruce E Maryanoff
Michael Hawkins
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of NO20012939D0 publication Critical patent/NO20012939D0/no
Publication of NO20012939L publication Critical patent/NO20012939L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20012939A 1998-12-14 2001-06-14 Substituerte, heterosykliske asyl-tripeptider for bruk som trombinreseptormodulatorer NO20012939L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11231398P 1998-12-14 1998-12-14
US44432799A 1999-11-19 1999-11-19
PCT/US1999/027570 WO2000035942A1 (en) 1998-12-14 1999-11-19 Substituted heterocyclic acyl-tripeptides useful as thrombin receptor modulators

Publications (2)

Publication Number Publication Date
NO20012939D0 NO20012939D0 (no) 2001-06-14
NO20012939L true NO20012939L (no) 2001-08-09

Family

ID=26809819

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012939A NO20012939L (no) 1998-12-14 2001-06-14 Substituerte, heterosykliske asyl-tripeptider for bruk som trombinreseptormodulatorer

Country Status (13)

Country Link
US (2) US6747127B1 (no)
EP (1) EP1140985A1 (no)
CN (1) CN1342164A (no)
AU (1) AU771844B2 (no)
BR (1) BR9916811A (no)
CA (1) CA2355818A1 (no)
CZ (1) CZ20012136A3 (no)
HU (1) HUP0104588A3 (no)
NO (1) NO20012939L (no)
PL (1) PL348504A1 (no)
TR (1) TR200102502T2 (no)
WO (1) WO2000035942A1 (no)
YU (1) YU42401A (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20060293231A1 (en) * 2004-07-30 2006-12-28 Regina Landesberg Method for enhancing bone formation
US20060159663A1 (en) * 2004-07-30 2006-07-20 Lu Helen H Growth factor encapsulation system for enhancing bone formation
WO2007129952A1 (en) * 2006-05-09 2007-11-15 Neobiotics Ab Novel peptide derivatives useful as antimicrobial agents for treating wounds
JP5296688B2 (ja) 2006-09-11 2013-09-25 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺虫化合物
CN101747410B (zh) * 2008-11-28 2013-03-13 北京大学 具镇痛活性的氨基酰酪氨酰色氨酸三肽及制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
GB9019558D0 (en) 1990-09-07 1990-10-24 Szelke Michael Enzyme inhibitors
US5391705A (en) 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
EP0503203A1 (en) 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
HU221974B1 (hu) 1992-06-04 2003-03-28 Merrell Dow Pharmaceuticals Inc. Eljárás trombingátló hatású fluortartalmú peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5696231A (en) 1994-12-21 1997-12-09 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
US6069232A (en) 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US6017890A (en) 1998-02-19 2000-01-25 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetics as thrombin receptor antagonists
AU2590799A (en) * 1998-02-19 1999-09-06 Ortho-Mcneil Pharmaceutical, Inc. Azole peptidomimetics as thrombin receptor antagonists

Also Published As

Publication number Publication date
HUP0104588A3 (en) 2002-05-28
YU42401A (sh) 2003-12-31
US20040063903A1 (en) 2004-04-01
CZ20012136A3 (cs) 2002-02-13
CN1342164A (zh) 2002-03-27
EP1140985A1 (en) 2001-10-10
TR200102502T2 (tr) 2002-05-21
AU1825600A (en) 2000-07-03
HUP0104588A2 (hu) 2002-04-29
US6747127B1 (en) 2004-06-08
PL348504A1 (en) 2002-05-20
AU771844B2 (en) 2004-04-01
NO20012939D0 (no) 2001-06-14
US7312306B2 (en) 2007-12-25
CA2355818A1 (en) 2000-06-22
BR9916811A (pt) 2002-01-15
WO2000035942A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
DK1133474T3 (da) 3-Substituerede 4-arylquinolin-2-onderivater som kaliumkanal-modulatorer
DK1140085T3 (da) Azabicycloalkan som CCR5-modulatorer
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
NO20004121D0 (no) Nye forbindelser og deres anvendelse som positive AMPA- reseptormodulatorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO985225D0 (no) Indolderivater nyttige som endotelinreseptorantagonister
DK1526134T3 (da) Triazolyltropanderivater som CCR5-modulatorer
NO20013149L (no) Piperidiner som CCR5-modulatorer
DK1444215T3 (da) 1,2,4-Thiadiazoliumderivater som melanocortinreceptormodulatorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20022649L (no) Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer
DK0946512T3 (da) 6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer
DK2020408T3 (da) Pyrrol-substitueret 2-indolinon som proteinkinaseinhibitor
NO20051042L (no) Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
NO20003451D0 (no) 2,3-substituerte indolforbindelser som cox-2 inhibitorer
NO20001141D0 (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001142L (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
NO20001139L (no) Aromatisk C16-C20-substituert tetrahydro-prostaglandiner anvendbare som FP-agonister
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
NO20015247D0 (no) Glysinspaltingssysteminhibitorer som potensielle antipsykotika
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO994106L (no) Oksazolidiner som 5-HT2A-antagonister
DK0912556T3 (da) Indolinderivater, der er anvendelige som 5-HT-2C-receptorantagonister
NO20006227L (no) Tetrahydroquiolinderivater som glycin antagonister
DK1075471T3 (da) Idolylderivater som serotonerge midler